Huaiyang Zhu
Overview
Explore the profile of Huaiyang Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhu H, Zheng C, Liu H, Kong F, Kong S, Chen F, et al.
Front Immunol
. 2022 Oct;
13:1028440.
PMID: 36311801
Purpose: To investigate the significance of macrophage infiltration to the prognosis of lung adenocarcinoma. Methods: R language bioinformatics analysis technology, was used to obtain macrophage infiltration-related module genes through WGCNA...
2.
Xiong Y, Yang C, Yang X, Ding C, Wang Q, Zhu H
Pathol Res Pract
. 2022 Aug;
237:153941.
PMID: 35933883
The aberrantly expressed long non-coding RNAs (lncRNAs) are closely correlated with the malignant progression of cancer cells. In our study, we identified lncRNA MIR9-3 host gene (MIR9-3HG) as the research...
3.
Zhu H, Liu Q, Yang X, Ding C, Wang Q, Xiong Y
Cancer Gene Ther
. 2022 Mar;
29(8-9):1285-1295.
PMID: 35228660
Lung squamous cell carcinoma (LUSC) represents one of the commonest types of lung cancer featured with high morbidity and poor prognosis. Many types of research have documented that long noncoding...
4.
Zhu H, Zhou Y, Wang Q, Yang X, Ding C, Xiong Y
Biochem Biophys Res Commun
. 2021 Aug;
574:56-62.
PMID: 34438347
The long noncoding RNAs (lncRNAs) have been shown to actively participate in various biological processes including cancer progression. However, most lncRNAs still have undefined functions. In current work, we identified...
5.
Johannessen T, Hasan-Olive M, Zhu H, Denisova O, Grudic A, Latif M, et al.
Int J Cancer
. 2018 Oct;
144(7):1735-1745.
PMID: 30289977
Glioblastoma multiforme (GBM) has a poor prognosis with an overall survival of 14-15 months after surgery, radiation and chemotherapy using temozolomide (TMZ). A major problem is that the tumors acquire...
6.
Zhu H, Leiss L, Yang N, Rygh C, Mitra S, Cheshier S, et al.
Oncotarget
. 2017 Jan;
8(7):12145-12157.
PMID: 28076333
Surgical resection is a standard component of treatment in the clinical management of patients with glioblastoma multiforme (GBM). However, experimental therapies are rarely investigated in the context of tumor debulking...
7.
Xiong Y, Gao X, Zhu H, Ding C, Wang J
J Thorac Dis
. 2016 Feb;
8(1):52-60.
PMID: 26904212
Background: Fibrous tuberculous pleural effusion (TPE) represents common disease in tuberculous clinic. Medical thoracoscopy has been used to treat pleural empyema and shown promising outcomes, but data of its use...
8.
Yang N, Huang B, Tsinkalovsky O, Brekka N, Zhu H, Leiss L, et al.
Cancer Cell Int
. 2015 Feb;
14(1):541.
PMID: 25663822
Backgroud: A key strategy for the study of the tumor microenvironment is to implant human tumor cells in an immunodeficient rodent strain ubiquitously expressing a fluorescent marker. Here, a novel...
9.
Yang N, Yan T, Zhu H, Liang X, Leiss L, Sakariassen P, et al.
J Transl Med
. 2014 Oct;
12:278.
PMID: 25280402
Background: Although several studies suggest that stromal fibroblasts mediate treatment resistance in several cancer types, little is known about how tumor-associated astrocytes modulate the treatment response in brain tumors. Since...